Guardion Health Sciences Inc

Guardion Health Sciences — Investor Presentation (October 2021)

9 slides from Guardion Health Sciences's investor presentation, Oct 22, 2021

  1. Slide 1: Shape the future with momentum

    Slide 1: Shape the future with momentum

    Shape the future with momentum Guardion is a company. driven by innovation, working to improve quality of life through our clinical nutrition products. HEALTH SCIENCES GUARDION 1 October 2021

  2. Slide 2: Forward Looking Statement

    Slide 2: Forward Looking Statement

    ’ Forward Looking Statement This presentation of Guardion Health Sciences, Inc. (the “Company,” “Guardion,” “we,” “us,” or “our”) includes "forward-looking statements" intended to - qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These

  3. Slide 3: Guardion Health Sciences Corporate Overview

    Slide 3: Guardion Health Sciences Corporate Overview

    ~ Guardion Health Sciences (Nasdaq: GHSI) is a clinical nutrition and diagnostics company that offers a portfolio of science-based, clinically- supported nutritional supplements, medical foods, and diagnostic products that support healthcare professionals, their patients, and consumers in achieving

  4. Slide 4: Synergy between Viactiv and legacy organization will accelerate growth

    Slide 4: Synergy between Viactiv and legacy organization will accelerate growth

    7 /Synergy between Viactiv and legacy Organization / will Accelerate Growth : Guardion Guardion = of 2021 re-Viactiv i“ ) oO (and beyond) Clinical investment Strong brand Scientific advisors Consumer-loved products Doctor education Marketing expertise Extensive Distribution Channels GUARDION HEALTH

  5. Slide 5: Highlights

    Slide 5: Highlights

    ’ Highlights “+ Well-positioned to compete in the large and growing global nutrition market with differentiated and established product portfolio focused on bone, ocular, and immune health ** Well defined value creation process focused on clinical evidence, product development and targeted marketing

  6. Slide 6: Financial Highlights

    Slide 6: Financial Highlights

    ” Financial Highlights * Closed the Viactiv acquisition on June 1, 2021 “ For 2Q21, total revenue was $1.2 M; Viactiv contributed for one month during the quarter and represented ~86% of GHSI total sales “» Cash and short-term investments at 6/30/21 were $12.5M and working capital was $14.7M; No deb

  7. Slide 7: Strategic Priorities — Driving Growth and Creating Value

    Slide 7: Strategic Priorities — Driving Growth and Creating Value

    Strategic Priorities — Driving Growth and Creating Value Brand Strategy — developing a strategy that best ae . . 1) ws leverages Viactiv’s strong consumer awareness and acceptance Product Strategy — focusing product portfolio on differentiated formulations, product taste, compelling product formats,

  8. Slide 8: Corporate Growth Timeline

    Slide 8: Corporate Growth Timeline

    7] Corporate Growth Timeline Potential Actions Through Year End 2022 * Improve communications channels * Complete and implement the results of business unit and product evaluation * New product development and product launches * Cost reduction activities and optimizing internal processes * Ramp up o

  9. Slide 9: Guardion Health Sciences is a clinical nutrition and diagnostics company

    Slide 9: Guardion Health Sciences is a clinical nutrition and diagnostics company

    Guardion Health Sciences is a clinical nutrition and diagnostics GUARDION company that offers a portfolio of science-based, clinically- supported nutritional supplements, medical foods, and HEALTH SCIENCES diagnostic products that support healthcare professionals, their patients, and consumers in ac

Source: SEC EDGAR · 8-K filed Oct 22, 2021

More decks from Guardion Health Sciences Inc